CINXE.COM
Time resolved amplified FRET identifies protein kinase B activation state as a marker for poor prognosis in clear cell renal cell carcinoma - PMC
<!DOCTYPE html> <html lang="en" > <head > <meta charset="UTF-8" /> <meta http-equiv="X-UA-Compatible" content="IE=edge" /> <meta name="HandheldFriendly" content="True" /> <meta name="MobileOptimized" content="320" /> <meta name="viewport" content="width=device-width, initial-scale=1.0" /> <link rel="stylesheet" href="/static/assets/style-70b9163a.css" /> <script type="module" crossorigin="" src="/static/assets/base_style-ec2bc71e.js"></script> <link rel="stylesheet" href="/static/assets/style-ef962842.css" /> <link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" /> <script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script> <style> @media screen and (min-width: 64em) { div.pmc-wm { background: repeat-y; background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E"); padding-left: 3rem; } } </style> <link rel="apple-touch-icon" sizes="180x180" href="/static/img/favicons/apple-touch-icon.png" /> <link rel="icon" type="image/png" sizes="48x48" href="/static/img/favicons/favicon-48x48.png" /> <link rel="icon" type="image/png" sizes="32x32" href="/static/img/favicons/favicon-32x32.png" /> <link rel="icon" type="image/png" sizes="16x16" href="/static/img/favicons/favicon-16x16.png" /> <link rel="manifest" href="/static/img/favicons/site.webmanifest" /> <link rel="mask-icon" href="/static/img/favicons/safari-pinned-tab.svg" color="#0071bc" /> <meta name="msapplication-config" content="/static/img/favicons/browserconfig.xml" /> <meta name="theme-color" content="#ffffff" /> <title> Time resolved amplified FRET identifies protein kinase B activation state as a marker for poor prognosis in clear cell renal cell carcinoma - PMC </title> <!-- Logging params: Pinger defaults --> <meta name="ncbi_app" content="cloudpmc-viewer" /> <meta name="ncbi_db" content="pmc" /> <meta name="ncbi_phid" content="E5FD3475741597630334750008C1B18A.m_1" /> <!-- Logging params: Pinger custom --> <meta name="ncbi_pdid" content="article" /> <link rel="preconnect" href="https://www.google-analytics.com" /> <link rel="dns-prefetch" href="https://cdn.ncbi.nlm.nih.gov" /> <link rel="preconnect" href="https://code.jquery.com" /> <meta name="ncbi_domain" content="bbac"> <meta name="ncbi_type" content="fulltext"> <meta name="ncbi_pcid" content="journal"> <meta name="ncbi_feature" content="associated_data"> <link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5744020/"> <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"> <meta name="citation_journal_title" content="BBA Clinical"> <meta name="citation_title" content="Time resolved amplified FRET identifies protein kinase B activation state as a marker for poor prognosis in clear cell renal cell carcinoma"> <meta name="citation_author" content="James Miles"> <meta name="citation_author_institution" content="Cell Biophysics Laboratory, Ikerbasque, Basque Foundation for Science, FASTBASE SOLUTIONS Ltd, Research Centre for Experimental Marine Biology and Biotechnology (PiE) & Biofísika Institute (UPV/EHU, CSIC), University of the Basque Country, Spain"> <meta name="citation_author_institution" content="Department of Pharmacy and Pharmacology, University of Bath, UK"> <meta name="citation_author_institution" content="Department of Pathology, Cruces University Hospital, Biocruces Research Institute, University of the Basque Country (UPV/EHU), Barakaldo, Spain"> <meta name="citation_author" content="Christopher J Applebee"> <meta name="citation_author_institution" content="Cell Biophysics Laboratory, Ikerbasque, Basque Foundation for Science, FASTBASE SOLUTIONS Ltd, Research Centre for Experimental Marine Biology and Biotechnology (PiE) & Biofísika Institute (UPV/EHU, CSIC), University of the Basque Country, Spain"> <meta name="citation_author" content="Pierre Leboucher"> <meta name="citation_author_institution" content="Institut du Cerveau et de la Moelle épinière, Hôpital de la Pitié-Salpêtrière, Paris, France"> <meta name="citation_author" content="Sonia Lopez-Fernandez"> <meta name="citation_author_institution" content="Cell Biophysics Laboratory, Ikerbasque, Basque Foundation for Science, FASTBASE SOLUTIONS Ltd, Research Centre for Experimental Marine Biology and Biotechnology (PiE) & Biofísika Institute (UPV/EHU, CSIC), University of the Basque Country, Spain"> <meta name="citation_author" content="Dae-Jin Lee"> <meta name="citation_author_institution" content="Basque Centre for Applied Mathematics, Bilbao, Bizkaia, Spain"> <meta name="citation_author" content="Rosa Guarch"> <meta name="citation_author_institution" content="Department of Pathology B, Complejo Hospitalario de Navarra, Pamplona, Spain"> <meta name="citation_author" content="Stephen Ward"> <meta name="citation_author_institution" content="Department of Pharmacy and Pharmacology, University of Bath, UK"> <meta name="citation_author" content="Peter J Parker"> <meta name="citation_author_institution" content="Protein Phosphorylation Laboratory, The Francis Crick Institute, London, UK and Division of Cancer Studies, King's College London, London, UK"> <meta name="citation_author" content="Jose I López"> <meta name="citation_author_institution" content="Department of Pathology, Cruces University Hospital, Biocruces Research Institute, University of the Basque Country (UPV/EHU), Barakaldo, Spain"> <meta name="citation_author" content="Banafshé Larijani"> <meta name="citation_author_institution" content="Cell Biophysics Laboratory, Ikerbasque, Basque Foundation for Science, FASTBASE SOLUTIONS Ltd, Research Centre for Experimental Marine Biology and Biotechnology (PiE) & Biofísika Institute (UPV/EHU, CSIC), University of the Basque Country, Spain"> <meta name="citation_publication_date" content="2017 Oct 13"> <meta name="citation_volume" content="8"> <meta name="citation_firstpage" content="97"> <meta name="citation_doi" content="10.1016/j.bbacli.2017.10.002"> <meta name="citation_pmid" content="29296589"> <meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC5744020/"> <meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC5744020/"> <meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC5744020/pdf/main.pdf"> <meta name="description" content="Clear cell Renal Cell Carcinomas (ccRCC), the largest group of renal tumours, are resistant to classical therapies. The determination of the functional state of actionable biomarkers for the assessment of these adenocarcinomas is essential. The ..."> <meta name="og:title" content="Time resolved amplified FRET identifies protein kinase B activation state as a marker for poor prognosis in clear cell renal cell carcinoma"> <meta name="og:type" content="article"> <meta name="og:site_name" content="PubMed Central (PMC)"> <meta name="og:description" content="Clear cell Renal Cell Carcinomas (ccRCC), the largest group of renal tumours, are resistant to classical therapies. The determination of the functional state of actionable biomarkers for the assessment of these adenocarcinomas is essential. The ..."> <meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC5744020/"> <meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0"> <meta name="twitter:card" content="summary_large_image"> <meta name="twitter:site" content="@ncbi"> </head> <body > <a class="usa-skipnav " href="#main-content"> Skip to main content </a> <section class="usa-banner " aria-label="Official website of the United States government" > <div class="usa-accordion"> <header class="usa-banner__header"> <div class="usa-banner__inner"> <div class="grid-col-auto"> <img aria-hidden="true" class="usa-banner__header-flag" src="/static/img/us_flag.svg" alt="" /> </div> <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true"> <p class="usa-banner__header-text"> An official website of the United States government </p> <span class="usa-banner__header-action">Here's how you know</span> </div> <button type="button" class="usa-accordion__button usa-banner__button " aria-expanded="false" aria-controls="gov-banner-default" data-testid="storybook-django-banner" > <span class="usa-banner__button-text">Here's how you know</span> </button> </div> </header> <div class="usa-banner__content usa-accordion__content" id="gov-banner-default" hidden> <div class="grid-row grid-gap-lg"> <div class="usa-banner__guidance tablet:grid-col-6"> <img class="usa-banner__icon usa-media-block__img" src="/static/img/icon-dot-gov.svg" alt="" aria-hidden="true" /> <div class="usa-media-block__body"> <p> <strong>Official websites use .gov</strong> <br /> A <strong>.gov</strong> website belongs to an official government organization in the United States. </p> </div> </div> <div class="usa-banner__guidance tablet:grid-col-6"> <img class="usa-banner__icon usa-media-block__img" src="/static/img/icon-https.svg" alt="" aria-hidden="true" /> <div class="usa-media-block__body"> <p> <strong>Secure .gov websites use HTTPS</strong> <br /> A <strong>lock</strong> ( <span class="icon-lock"> <svg xmlns="http://www.w3.org/2000/svg" width="52" height="64" viewBox="0 0 52 64" class="usa-banner__lock-image" role="graphics-symbol" aria-labelledby="banner-lock-description" focusable="false"> <title id="banner-lock-title">Lock</title> <desc id="banner-lock-description"> Locked padlock icon </desc> <path fill="#000000" fill-rule="evenodd" d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" /> </svg> </span>) or <strong>https://</strong> means you've safely connected to the .gov website. Share sensitive information only on official, secure websites. </p> </div> </div> </div> </div> </div> </section> <div class="usa-overlay"> </div> <header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header > <div class="ncbi-header"> <div class="ncbi-header__container"> <a class="ncbi-header__logo-container" href="/"> <img alt=" PMC home page " class="ncbi-header__logo-image" src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" /> </a> <!-- Mobile menu hamburger button --> <button type="button" class="usa-menu-btn ncbi-header__hamburger-button " aria-label="Show menu" data-testid="navMenuButton" > <svg aria-hidden="true" class="ncbi-hamburger-icon" fill="none" focusable="false" height="21" viewBox="0 0 31 21" width="31" xmlns="http://www.w3.org/2000/svg"> <path clip-rule="evenodd" d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z" fill="#F1F1F1" fill-rule="evenodd" /> </svg> </button> <!-- Desktop buttons--> <div class="ncbi-header__desktop-buttons"> <!-- Desktop search button --> <button type="button" class="usa-button usa-button--unstyled ncbi-header__desktop-button " aria-expanded="false" aria-controls="search-field-desktop-navigation" aria-label="Show search overlay" data-testid="toggleSearchPanelButton" data-toggle-search-panel-button > <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" > <use xlink:href="/static/img/sprite.svg#search" /> </svg> Search </button> <!-- Desktop login dropdown --> <div class="ncbi-header__login-dropdown"> <button type="button" class="usa-button usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button " aria-expanded="false" aria-controls="login-dropdown-menu" aria-label="Show login menu" data-testid="toggleLoginMenuDropdown" data-desktop-login-button > <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" > <use xlink:href="/static/img/sprite.svg#person" /> </svg> <span data-login-dropdown-text>Log in</span> <!-- Dropdown icon pointing up --> <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow> <use xlink:href="/static/img/sprite.svg#expand_less" /> </svg> <!-- Dropdown icon pointing down --> <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow> <use xlink:href="/static/img/sprite.svg#expand_more" /> </svg> </button> <!-- Login dropdown menu --> <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu" id="login-dropdown-menu" data-desktop-login-menu-dropdown hidden> <li class="usa-nav__submenu-item"> <!-- Uses custom style overrides to render external and document links. --> <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link " > Dashboard </a> </li> <li class="usa-nav__submenu-item"> <!-- Uses custom style overrides to render external and document links. --> <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link " > Publications </a> </li> <li class="usa-nav__submenu-item"> <!-- Uses custom style overrides to render external and document links. --> <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link " > Account settings </a> </li> <li class="usa-nav__submenu-item"> <button type="button" class="usa-button usa-button--outline ncbi-header__login-dropdown-logout-button " data-testid="desktopLogoutButton" data-desktop-logout-button > Log out </button> </li> </ul> </div> </div> </div> </div> <!-- Search panel --> <div class="ncbi-search-panel ncbi--show-only-at-desktop" data-testid="searchPanel" data-header-search-panel hidden> <div class="ncbi-search-panel__container"> <form action="https://www.ncbi.nlm.nih.gov/search/all/" aria-describedby="search-field-desktop-navigation-help-text" autocomplete="off" class="usa-search usa-search--big ncbi-search-panel__form" data-testid="form" method="GET" role="search"> <label class="usa-sr-only" data-testid="label" for="search-field-desktop-navigation"> Search… </label> <input class="usa-input" data-testid="textInput" id="search-field-desktop-navigation" name="term" placeholder="Search NCBI" type="search" value="" /> <button type="submit" class="usa-button " data-testid="button" > <span class="usa-search__submit-text"> Search NCBI </span> </button> </form> </div> </div> <nav aria-label="Primary navigation" class="usa-nav"> <p class="usa-sr-only" id="primary-navigation-sr-only-title"> Primary site navigation </p> <!-- Mobile menu close button --> <button type="button" class="usa-nav__close ncbi-nav__close-button " aria-label="Close navigation menu" data-testid="navCloseButton" > <img src="/static/img/usa-icons/close.svg" alt="Close" /> </button> <!-- Mobile search component --> <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6" role="search"> <label class="usa-sr-only" for="search-field"> Search </label> <input class="usa-input" id="search-field-mobile-navigation" type="search" placeholder="Search NCBI" name="search" /> <button type="submit" class="usa-button " > <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color --> <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg==" class="usa-search__submit-icon" alt="Search" /> </button> </form> <!-- Primary navigation menu items --> <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop --> <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop" data-mobile-login-menu hidden> <p class="ncbi-nav__mobile-login-menu-status"> Logged in as: <strong class="ncbi-nav__mobile-login-menu-email" data-mobile-login-email-text></strong> </p> <ul class="usa-nav__primary usa-accordion"> <li class="usa-nav__primary-item"> <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link " > Dashboard </a> </li> <li class="usa-nav__primary-item"> <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link " > Publications </a> </li> <li class="usa-nav__primary-item"> <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link " > Account settings </a> </li> </ul> </div> <button type="button" class="usa-button ncbi-nav__mobile-login-button ncbi--hide-at-desktop " data-testid="mobileLoginButton" data-mobile-login-button > Log in </button> </nav> </header> <section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box"> <div class="pmc-nav-container"> <div class="pmc-header__bar"> <div class="pmc-header__logo"> <a href="/" title="Home" aria-label="PMC Home"></a> </div> <button type="button" class="usa-button usa-button--unstyled pmc-header__search__button" aria-label="Open search" data-ga-category="search" data-ga-action="PMC" data-ga-label="pmc_search_panel_mobile" > <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#search"></use> </svg> <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#close"></use> </svg> </button> </div> <div class="pmc-header__search"> <form class="usa-search usa-search--extra usa-search--article-right-column pmc-header__search__form" autocomplete="off" role="search"> <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label> <span class="autoComplete_wrapper flex-1"> <input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search" type="search" name="term" data-autocomplete-url="/search/autocomplete/"/> </span> <button class="usa-button" type="submit" formaction="https://www.ncbi.nlm.nih.gov/pmc/" data-ga-category="search" data-ga-action="PMC" data-ga-label="PMC_search_button" > <span class="usa-search__submit-text">Search in PMC</span> <img src="/static/img/usa-icons-bg/search--white.svg" class="usa-search__submit-icon" alt="Search" /> </button> </form> <ul class="pmc-header__search__menu"> <li> <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search"> Advanced Search </a> </li> <li> <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list"> Journal List </a> </li> <li> <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link" data-ga-label="user guide"> User Guide </a> </li> </ul> </div> </div> </section> <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="5744020"> <div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary"> <div class="grid-row"> <div class="grid-col-fill display-flex"> <div class="display-flex"> <ul class="usa-list usa-list--unstyled usa-list--horizontal"> <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob"> <button type="button" class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex" aria-label="Open resources" data-extra-class="is-visible-resources" data-ga-category="resources_accordion" data-ga-action="click" data-ga-label="mobile_icon" > <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#more_vert"></use> </svg> </button> </li> <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob"> <a href="https://doi.org/10.1016/j.bbacli.2017.10.002" class="usa-link display-flex" role="button" target="_blank" rel="noreferrer noopener" aria-label="View on publisher site" data-ga-category="actions" data-ga-action="click" data-ga-label="publisher_link_mobile" > <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#launch"></use> </svg> </a> </li> <li class="margin-right-2 mobile-lg:margin-right-4 display-flex"> <a href="pdf/main.pdf" class="usa-link display-flex" role="button" aria-label="Download PDF" data-ga-category="actions" data-ga-action="click" data-ga-label="pdf_download_mobile" > <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#file_download"></use> </svg> </a> </li> <li class="margin-right-2 mobile-lg:margin-right-4 display-flex"> <button class="usa-button usa-button--unstyled collections-dialog-trigger collections-button display-flex collections-button-empty" aria-label="Save article in MyNCBI collections." data-ga-category="actions" data-ga-action="click" data-ga-label="collections_button_mobile" data-collections-open-dialog-enabled="false" data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC5744020%2F%23open-collections-dialog" data-in-collections="false" > <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden> <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use> </svg> <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden> <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use> </svg> </button> </li> <li class="margin-right-2 mobile-lg:margin-right-4 display-flex"> <button role="button" class="usa-button usa-button--unstyled citation-dialog-trigger display-flex" aria-label="Open dialog with citation text in different styles" data-ga-category="actions" data-ga-action="open" data-ga-label="cite_mobile" data-all-citations-url="/resources/citations/5744020/" data-citation-style="nlm" data-download-format-link="/resources/citations/5744020/export/" > <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden> <use xlink:href="/static/img/sprite.svg#format_quote"></use> </svg> </button> </li> <li class="pmc-permalink display-flex"> <button type="button" class="usa-button usa-button--unstyled display-flex" aria-label="Show article permalink" aria-expanded="false" aria-haspopup="true" data-ga-category="actions" data-ga-action="open" data-ga-label="permalink_mobile" > <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#share"></use> </svg> </button> <div class="pmc-permalink__dropdown" hidden> <div class="pmc-permalink__dropdown__container"> <h2 class="usa-modal__heading margin-top-0 margin-bottom-2">PERMALINK</h2> <div class="pmc-permalink__dropdown__content"> <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC5744020/" aria-label="Article permalink"> <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link"> <svg class="usa-icon" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#content_copy"></use> </svg> <span class="margin-left-1">Copy</span> </button> </div> </div> </div> </li> </ul> </div> <button type="button" class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex" aria-label="Open article navigation" data-extra-class="is-visible-in-page" data-ga-category="actions" data-ga-action="open" data-ga-label="article_nav_mobile" > <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#list"></use> </svg> </button> </div> </div> </div> <div class="grid-container desktop:padding-left-6"> <div id="article-container" class="grid-row grid-gap"> <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content"> <div class="grid-container padding-left-0 padding-right-0"> <div class="grid-row desktop:margin-left-neg-6"> <div class="grid-col-12"> <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note"> As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health.<br/> Learn more: <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a> | <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/"> PMC Copyright Notice </a> </div> </div> </div> <div class="grid-row pmc-wm desktop:margin-left-neg-6"> <!-- Main content --> <main id="main-content" class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0" > <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-bbac.gif" alt="BBA Clinical logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to BBA Clinical" title="Link to BBA Clinical" shape="default" href="http://www.journals.elsevier.com/bba-clinical" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div> <div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">BBA Clin</button></div>. 2017 Oct 13;8:97–102. doi: <a href="https://doi.org/10.1016/j.bbacli.2017.10.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1016/j.bbacli.2017.10.002</a> </div> <nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu"> <li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22BBA%20Clin%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li> <li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22BBA%20Clin%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li> <li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22BBA%20Clin%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li> <li role="presentation"><a href="?term=%22BBA%20Clin%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li> </ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs"> <hgroup><h1>Time resolved amplified FRET identifies protein kinase B activation state as a marker for poor prognosis in clear cell renal cell carcinoma</h1></hgroup><div class="cg p"> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Miles%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">James Miles</span></a><div hidden="hidden" id="id1"> <h3><span class="name western">James Miles</span></h3> <div class="p"> <sup>a</sup>Cell Biophysics Laboratory, Ikerbasque, Basque Foundation for Science, FASTBASE SOLUTIONS Ltd, Research Centre for Experimental Marine Biology and Biotechnology (PiE) & Biofísika Institute (UPV/EHU, CSIC), University of the Basque Country, Spain</div> <div class="p"> <sup>e</sup>Department of Pharmacy and Pharmacology, University of Bath, UK</div> <div class="p"> <sup>g</sup>Department of Pathology, Cruces University Hospital, Biocruces Research Institute, University of the Basque Country (UPV/EHU), Barakaldo, Spain</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Miles%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">James Miles</span></a> </div> </div> <sup>a,</sup><sup>e,</sup><sup>g</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Applebee%20CJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Christopher J Applebee</span></a><div hidden="hidden" id="id2"> <h3><span class="name western">Christopher J Applebee</span></h3> <div class="p"> <sup>a</sup>Cell Biophysics Laboratory, Ikerbasque, Basque Foundation for Science, FASTBASE SOLUTIONS Ltd, Research Centre for Experimental Marine Biology and Biotechnology (PiE) & Biofísika Institute (UPV/EHU, CSIC), University of the Basque Country, Spain</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Applebee%20CJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Christopher J Applebee</span></a> </div> </div> <sup>a</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Leboucher%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Pierre Leboucher</span></a><div hidden="hidden" id="id3"> <h3><span class="name western">Pierre Leboucher</span></h3> <div class="p"> <sup>b</sup>Institut du Cerveau et de la Moelle épinière, Hôpital de la Pitié-Salpêtrière, Paris, France</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Leboucher%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Pierre Leboucher</span></a> </div> </div> <sup>b</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lopez-Fernandez%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Sonia Lopez-Fernandez</span></a><div hidden="hidden" id="id4"> <h3><span class="name western">Sonia Lopez-Fernandez</span></h3> <div class="p"> <sup>a</sup>Cell Biophysics Laboratory, Ikerbasque, Basque Foundation for Science, FASTBASE SOLUTIONS Ltd, Research Centre for Experimental Marine Biology and Biotechnology (PiE) & Biofísika Institute (UPV/EHU, CSIC), University of the Basque Country, Spain</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lopez-Fernandez%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sonia Lopez-Fernandez</span></a> </div> </div> <sup>a</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lee%20DJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Dae-Jin Lee</span></a><div hidden="hidden" id="id5"> <h3><span class="name western">Dae-Jin Lee</span></h3> <div class="p"> <sup>c</sup>Basque Centre for Applied Mathematics, Bilbao, Bizkaia, Spain</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lee%20DJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Dae-Jin Lee</span></a> </div> </div> <sup>c</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Guarch%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Rosa Guarch</span></a><div hidden="hidden" id="id6"> <h3><span class="name western">Rosa Guarch</span></h3> <div class="p"> <sup>d</sup>Department of Pathology B, Complejo Hospitalario de Navarra, Pamplona, Spain</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Guarch%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rosa Guarch</span></a> </div> </div> <sup>d</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ward%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Stephen Ward</span></a><div hidden="hidden" id="id7"> <h3><span class="name western">Stephen Ward</span></h3> <div class="p"> <sup>e</sup>Department of Pharmacy and Pharmacology, University of Bath, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ward%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Stephen Ward</span></a> </div> </div> <sup>e</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Parker%20PJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Peter J Parker</span></a><div hidden="hidden" id="id8"> <h3><span class="name western">Peter J Parker</span></h3> <div class="p"> <sup>f</sup>Protein Phosphorylation Laboratory, The Francis Crick Institute, London, UK and Division of Cancer Studies, King's College London, London, UK</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Parker%20PJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Peter J Parker</span></a> </div> </div> <sup>f</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22L%C3%B3pez%20JI%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Jose I López</span></a><div hidden="hidden" id="id9"> <h3><span class="name western">Jose I López</span></h3> <div class="p"> <sup>g</sup>Department of Pathology, Cruces University Hospital, Biocruces Research Institute, University of the Basque Country (UPV/EHU), Barakaldo, Spain</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22L%C3%B3pez%20JI%22%5BAuthor%5D" class="usa-link"><span class="name western">Jose I López</span></a> </div> </div> <sup>g,</sup><sup>⁎</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Larijani%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Banafshé Larijani</span></a><div hidden="hidden" id="id10"> <h3><span class="name western">Banafshé Larijani</span></h3> <div class="p"> <sup>a</sup>Cell Biophysics Laboratory, Ikerbasque, Basque Foundation for Science, FASTBASE SOLUTIONS Ltd, Research Centre for Experimental Marine Biology and Biotechnology (PiE) & Biofísika Institute (UPV/EHU, CSIC), University of the Basque Country, Spain</div> <div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Larijani%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Banafshé Larijani</span></a> </div> </div> <sup>a,</sup><sup>⁎</sup> </div> <ul class="d-buttons inline-list"> <li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li> <li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li> <li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li> </ul> <div class="d-panels font-secondary-light"> <div id="aip_a" class="d-panel p" style="display: none"> <div class="p" id="af0005"> <sup>a</sup>Cell Biophysics Laboratory, Ikerbasque, Basque Foundation for Science, FASTBASE SOLUTIONS Ltd, Research Centre for Experimental Marine Biology and Biotechnology (PiE) & Biofísika Institute (UPV/EHU, CSIC), University of the Basque Country, Spain</div> <div id="af0010"> <sup>b</sup>Institut du Cerveau et de la Moelle épinière, Hôpital de la Pitié-Salpêtrière, Paris, France</div> <div id="af0015"> <sup>c</sup>Basque Centre for Applied Mathematics, Bilbao, Bizkaia, Spain</div> <div id="af0020"> <sup>d</sup>Department of Pathology B, Complejo Hospitalario de Navarra, Pamplona, Spain</div> <div id="af0025"> <sup>e</sup>Department of Pharmacy and Pharmacology, University of Bath, UK</div> <div id="af0030"> <sup>f</sup>Protein Phosphorylation Laboratory, The Francis Crick Institute, London, UK and Division of Cancer Studies, King's College London, London, UK</div> <div id="af0035"> <sup>g</sup>Department of Pathology, Cruces University Hospital, Biocruces Research Institute, University of the Basque Country (UPV/EHU), Barakaldo, Spain</div> <div class="author-notes p"><div class="fn" id="cr0005"> <sup>⁎</sup><p class="display-inline">Corresponding authors. <span>joseignacio.lopezfernandezdevillaverde@osakidetza.eus</span><span>banafshe.larijani@ikerbasque.org</span></p> </div></div> </div> <div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2017 Aug 10; Revised 2017 Oct 11; Accepted 2017 Oct 11; Collection date 2017 Dec.</p></section></div></div> <div id="clp_a" class="d-panel p" style="display: none"> <div>© 2017 The Authors</div> <p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</p> <div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div> </div> </div> <div>PMCID: PMC5744020 PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/29296589/" class="usa-link">29296589</a> </div> </div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="ab0005"><h2>Abstract</h2> <section id="sec1"><h3 class="pmc_sec_title">Purpose</h3> <p>Clear cell Renal Cell Carcinomas (ccRCC), the largest group of renal tumours, are resistant to classical therapies. The determination of the functional state of actionable biomarkers for the assessment of these adenocarcinomas is essential. The dysregulation of the oncoprotein, PKB/Akt has been linked with poor prognoses in human cancers.</p></section><section id="sec2"><h3 class="pmc_sec_title">Material & methods</h3> <p>We analysed the status of the PKB/Akt pathway in a representative tumour tissue microarray obtained from the primary tumours and their metastases in 60 ccRCC with long term follow up. We sought to define the evolution of this pathway from the primary tumour to the metastatic event and to know the impact of its functional state in tumour aggressiveness and patient survival. Two-site time resolved amplified FRET (A-FRET) was utilised for assessing the activation state of PKB/Akt and this was compared to conventional immunohistochemistry measurements.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3> <p>Activation state of PKB/Akt in primary tumours defined by A-FRET correlated with poorer overall survival (hazard ratio 0.228; <em>p</em> = 0.002). Whereas, increased protein expression of phosphoPKB/Akt, identified using classical immunohistochemistry, yielded no significant difference (hazard ratio 1.390; <em>p</em> = 0.548).</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusions</h3> <p>Quantitative determination of PKB/Akt activation in ccRCC primary tumours alongside other diagnostics tools could prove key in taking oncologists closer to an efficient personalised therapy in ccRCC patients.</p></section><section id="sec5"><h3 class="pmc_sec_title">General significance</h3> <p>The quantitative imaging technology based on Amplified-FRET can rapidly analyse protein activation states and molecular interactions. It could be used for prognosis and assess drug function during the early cycles of chemotherapy. It enables evaluation of clinical efficiency of personalised cancer treatment.</p></section><section id="ks0005" class="kwd-group"><p><strong>Keywords:</strong> Clear cell renal cell carcinoma, Protein kinase B (PKB/Akt), Amplified FRET, Prognosis, Fret-FLIM, Biomarker activation</p></section></section><section class="abstract" id="ab0010"><h2>Highlights</h2> <ul class="list" style="list-style-type:none"> <li id="li0005"> <span class="label">•</span><p class="display-inline" id="p0005">Time Resolved Amplified FRET (A-FRET), has been used to quantitatively assess PKB/Akt activation states in ccRCC.</p> </li> <li id="li0010"> <span class="label">•</span><p class="display-inline" id="p2005">Increased activation state of PKB/Akt in primary tumours was shown to correlate with poorer prognoses.</p> </li> <li id="li0015"> <span class="label">•</span><p class="display-inline" id="p2010">Companion diagnostic tools such as A-FRET will prove valuable for assessing prognostic models and for predicting the response to systemic therapy.</p> </li> </ul></section><section id="s0005"><h2 class="pmc_sec_title">1. Introduction</h2> <p id="p0010">Clear cell renal cell carcinomas (ccRCCs) are a major health concern in the West as they are quite a common aggressive radio- and chemo-resistant neoplasm <a href="#bb0005" class="usa-link" aria-describedby="bb0005">[1]</a>. Only surgery has demonstrated a significant impact in patient survival, the 5-year overall mortality of this neoplasm is still reaching around 40% <a href="#bb0010" class="usa-link" aria-describedby="bb0010">[2]</a>. Truncal mutations in the Von Hippel–Lindau <em>VHL</em> tumour suppressor gene are the hallmark of this pathology, but therapies against this target have elicited, to date, only partial responses. These disappointing results are mainly related to the inherent high intratumoral heterogeneity (ITH) that ccRCCs display to the point that ITH is nowadays a major obstacle to the implementation of efficient therapies impacting significantly on patient survival <a href="#bb0015" class="usa-link" aria-describedby="bb0015">[3]</a>.</p> <p id="p0015">The aim of this study is to determine whether the phosphoinositide 3-kinase (PI3K)/protein kinase B (PKB/Akt) dysregulation is implicated in the mechanisms underlying ccRCC carcinogenesis and its hypothetical impact on patient survival. To pursue this investigation a recently developed approach was utilised to determine the functional status of the PKB/Akt signalling pathway <a href="#bb0020" class="usa-link" aria-describedby="bb0020">[4]</a>.</p> <p id="p0020">Protein kinase B (PKB/Akt) is a kinase from the AGC kinase superfamily which promotes cell growth, survival and proliferation <a href="#bb0025" class="usa-link" aria-describedby="bb0025">[5]</a>, <a href="#bb0030" class="usa-link" aria-describedby="bb0030">[6]</a>. Upon the binding of a growth factor receptor to a receptor tyrosine kinase, phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P<sub>2</sub>) is phosphorylated, by phosphoinositide 3-kinase (PI3K) to phosphatidylinositol 3,4,5-triphosphate (PtdIns(3,4,5)P<sub>3</sub>). This transient formation of PtdIns(3,4,5)P<sub>3</sub> recruits PKB and phosphoinositide-dependent protein kinase 1 (PDK1) to the plasma membrane. Upon the change in conformation of PKB, PDK1 phosphorylates threonine-308 to partially active it <a href="#bb0035" class="usa-link" aria-describedby="bb0035">[7]</a>, <a href="#bb0040" class="usa-link" aria-describedby="bb0040">[8]</a>. Full activation is achieved by m-TOR in complex 2 which phosphorylates serine 473 <a href="#bb0045" class="usa-link" aria-describedby="bb0045">[9]</a>. An overview of the PKB signalling pathway is shown in <a href="#f0005" class="usa-link">Fig. 1</a>. PKB is known to be dysregulated in many human cancer <a href="#bb0025" class="usa-link" aria-describedby="bb0025">[5]</a>. This dysregulation can occur via the loss of inhibition through phosphatase and tensin homolog (PTEN) for example, or through the upregulation of the PI3K-Akt pathway <a href="#bb0030" class="usa-link" aria-describedby="bb0030">[6]</a>, <a href="#bb0050" class="usa-link" aria-describedby="bb0050">[10]</a>, <a href="#bb0055" class="usa-link" aria-describedby="bb0055">[11]</a>. Alternatively, a mutation of PKB itself could cause dysregulation within this pathway <a href="#bb0060" class="usa-link" aria-describedby="bb0060">[12]</a>.</p> <figure class="fig xbox font-sm" id="f0005" title="Fig. 1"><h3 class="obj_head">Fig. 1.</h3> <p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&p=PMC3&id=5744020_gr1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e15/5744020/08329ab2f430/gr1.jpg" loading="lazy" height="573" width="758" alt="Fig. 1"></a></p> <div class="p text-right font-secondary"><a href="figure/f0005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div> <figcaption><p>Schematic overview of the Protein Kinase B signalling pathway.</p> <p>Protein Kinase B (PKB/Akt) is part of the AGC kinase super family. Upon the binding of a growth factor receptor to a receptor tyrosine kinase, phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P<sub>2</sub>) is phosphorylated, by phosphoinositide 3-kinase (PI3K) to phosphatidylinositol 3,4,5-triphosphate (PtdIns(3,4,5)P<sub>3</sub>). This recruits PKB and phosphoinositide-dependent protein kinase 1 (PDK1) to the plasma membrane. PDK1 phosphorylates threonine-308 to partially active it and mTORC2 phosphorylates Ser473 for full activation.</p></figcaption></figure><p id="p0025">Currently, the use of fluorescent microscopy to detect protein expression is based on measuring the intensity and therefore proves to be imprecise; as well as lacking a dynamic range for providing a detailed view on the activation state of oncoproteins in the diagnosis and prognosis of various cancers. Assessing the expression levels of proteins does not provide information on the activation states of the protein in the advancement of a cancer. This is important as expression levels and activation states of oncoproteins do not necessarily correlate <a href="#bb0020" class="usa-link" aria-describedby="bb0020">[4]</a>, <a href="#bb0065" class="usa-link" aria-describedby="bb0065">[13]</a>. Our method uses amplified Förster Resonance Energy Transfer (FRET), detected by a multiple frequency domain fluorescent lifetime imaging microscopy (mf FLIM), to assess the activation of different oncoproteins in primary and metastatic tumours of the same patients. It has been previously shown that this method, when used to assess PKB activation in breast tumours, correlated a higher PKB activation with a worse prognosis <a href="#bb0020" class="usa-link" aria-describedby="bb0020">[4]</a>.</p> <p id="p0030">The principles of FRET involve the non-radiative transfer of energy from one chromophore to another via dipole-dipole interactions at a distance equal to or < 10 nm. An appropriately selected donor chromophore must have an emission spectrum that overlaps with the excitation spectrum of the chosen acceptor chromophore. When excited in the presence of an acceptor, the lifetime of a donor is decreased due to the depopulation of its excited state, where its energy is non-radiatively transferred to the acceptor chromophore <a href="#bb0070" class="usa-link" aria-describedby="bb0070">[14]</a>. The fluorescent labelling of PKB on both serine and threonine sites will experience FRET upon the increase in the activation state of PKB/Akt.</p> <p id="p0035">Exploiting this quantitative methodology has enabled us to show that the PKB/Akt activation in ccRCC primary tumours alongside other diagnostics tools could prove key in taking oncologists closer to an efficient personalised therapy in ccRCC patients.</p></section><section id="s0010"><h2 class="pmc_sec_title">2. Materials and methods</h2> <p id="p0040">The authors declare that all the experiments carried out in this study comply with current Spanish and European Union legal regulations. Samples and data from patients included in this study were obtained from the medical records and archives of the Pathology Lab (Cruces University Hospital). All patients were informed about the potential use for research of their surgically resected tissues, and accepted this eventuality by signing a specific document. This study was approved by the Ethical and Scientific Committee (CEIC-Euskadi PI2015060).</p> <section id="s0015"><h3 class="pmc_sec_title">2.1. Patient samples</h3> <p id="p0045">Two experienced uropathologists (RG, JIL) performed the pathological analysis, re-assigned grade and stage to all tumours and selected the appropriate tumour areas for analysis, including them in tumour microarrays (TMAs). The International Society of Urological Pathology (ISUP) 2013 tumour grading system <a href="#bb0075" class="usa-link" aria-describedby="bb0075">[15]</a> was assigned to every sample in the TMA on routine haematoxylin and eosin sections. Grade was grouped as low (G1/2) and high (G3/4) for higher consistency. UICC 2010 tumour staging system <a href="#bb0080" class="usa-link" aria-describedby="bb0080">[16]</a> was assigned to every case at the time of pathological diagnoses on nephrectomy specimens. Staging was grouped as pT1/2 (tumours confined to the kidney) and pT3 (tumours invading outside the kidney).</p></section><section id="s0020"><h3 class="pmc_sec_title">2.2. TMA preparation</h3> <p id="p0050">In every case, well preserved tumour areas of the highest grade, both in the primary tumour and its metastasis, were selected for analysis. Samples of 2.5 mm in diameter of these areas were obtained from the paraffin blocks and placed randomly in TMAs in a routine way to ensure a blind evaluation. Internal controls were included in all TMAs. Unstained 4 μm-thick samples of TMAs were mounted on slides ready for FRET analysis.</p></section><section id="s0025"><h3 class="pmc_sec_title">2.3. Antibodies and reagents</h3> <p id="p0055">Monoclonal antibodies, rabbit anti-pAkt and mouse anti-panAkt were purchased from Cell Signalling Technology. Pierce endogenous peroxidase suppressor was also obtained from Thermo Fisher Scientific (catalogue no. 35000). AffiniPure F(ab′)<sub>2</sub> fragment donkey anti-rabbit IgG and peroxidase-conjugated AffiniPure F(ab′)<sub>2</sub> fragment donkey anti-rabbit IgG were purchased from Jackson Immuno Research Laboratories. ATTO 488 NHS ester was purchased and was conjugated to the AffiniPure F(ab′)<sub>2</sub> IgG as described in <a href="#bb0020" class="usa-link" aria-describedby="bb0020">[4]</a>. Prolong diamond anti-fade mount (catalogue no. <a href="https://www.ncbi.nlm.nih.gov/protein/P36970" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P36970</a>), bovine serum albumin (BSA) blocking reagent, amplification buffer and tyramide were all obtained from Life Technologies (catalogue nos. T20915COMPONENT - D, E and A).</p></section><section id="s0030"><h3 class="pmc_sec_title">2.4. Förster resonance energy transfer (FRET) by fluorescence lifetime imaging microscopy (FLIM)</h3> <section id="s0035"><h4 class="pmc_sec_title">2.4.1. Two-site amplified FRET assay for PKB/Akt activation quantification</h4> <p id="p0060">The slides underwent de-waxing and rehydration followed by heat antigen retrieval in Tris-EDTA (pH 9.0) buffer. Slides were incubated with peroxidase suppressor for 30 min. Afterwards slides were incubated for 1 h with fresh 1% (10 mg/ml) BSA blocking buffer. Following this the slides were incubated overnight at 4 °C with the primary antibodies (pan-Akt 1:50, p-Akt 1:100). For secondary antibody labelling, donor only slides were incubated with Fab-ATTO488 (1:100) and donor acceptor slides with Fab-ATTO488 (1:100) and Fab-HRP (1:200) for 2 h at room temperature. Tyramide signal amplification was carried out on donor/acceptor slides. Fab-HRP is bound to the primary acceptor antibodies. Tyramide which is conjugated to Alexa594 is then added which, in the presence of H<sub>2</sub>O<sub>2,</sub> leads to the binding of the Alexa594 chromophore to the HRP molecule, thus fluorescently labelling the acceptor site. Slides were mounted with Prolong Diamond anti-fade mount.</p></section><section id="s0040"><h4 class="pmc_sec_title">2.4.2. Analysis of biomarker activation using multiple frequency domain FLIM</h4> <p id="p0065">Immunohistochemistry (IHC) and immunofluorescence (IF) both operate around a one-site assay whereas A-FRET employs the use of a two-site assay. A one-site assay detects only one antigen site at a time and induces non-specificity. A two-site assay detects two antigen sites simultaneously hence rendering an augmented precision. The conjugation of the chromophores to Fab fragments, which bind to the two primary antibodies, allowed the critical FRET distance of 10 nm or less to be kept and provided a suitable tool for measuring the activation state of a given biomarker. To detect the signal of a sample with good precision and overcome autofluorescence, especially in fixed tissue samples, a signal to noise ratio of at least 4-fold must be observed. To achieve this, tyramide signal amplification was carried out.</p> <p id="p0070">Using a high throughput mfFLIM (FASTBASE SOLUTIONS Ltd. and Lambert Instruments), a mapping file was created semi-automatically which mapped each tumour core according to its position on the slide. Mapping the whole tumour core allowed each sample to be analysed completely rather than using segmental analysis. Images and results were automatically acquired from the arrays according to their positioning. Phase, lifetimes and average intensities were all calculated automatically and saved as an excel file, as well as lifetime images.</p></section></section><section id="s0045"><h3 class="pmc_sec_title">2.5. Statistical analysis</h3> <p id="p0075">Statistical analysis was performed using the GraphPad Prism software to create Kaplan-Meier survival curves and Origin Pro8 used to provide statistical analysis and generate box and whisker plots. Statistical differences were calculated between groups using the Mann-Whitney <em>U</em> test (values indicated within the box and whisker plots). The Mann-Whitney U test is a nonparametric test which does not assume a normal distribution of results. <em>P</em> values ≤ 0.05 indicated a statistical difference from the null hypothesis. Box and whisker plots represent the 25–75% range (box) and the 1–99 range (whiskers). Statistical differences are indicated with <em>p</em> values ≤ 0.05. For Kaplan-Meier survival curves, overall survival was plotted, which calculated a patient's time from diagnosis until death or until the patient was last seen. The hazard ratio was also calculated for each Kaplan-Meier curve. Multivariate analysis was also performed to exclude influences among the evaluated parameters. A non-parametric Mann-Whitney <em>U</em> test was also used to see if there was correlation between different parameters and FRET efficiency or intensity and plotted as a Mann-Whitney plot.</p></section></section><section id="s0050"><h2 class="pmc_sec_title">3. Results</h2> <section id="s0055"><h3 class="pmc_sec_title">3.1. Patient data</h3> <p id="p0080">The series includes 60 patients diagnosed, treated and followed in the Cruces University Hospital from 1990 to 2014. Males predominated in the series (46 M/14F) with an average age of 58.5 years (range 25–83). Primary tumours were located in the right kidney in 29 cases and in the left kidney in 31 cases. The average tumour diameter was 8.5 cm (range 2–19). Thirty-two primary tumours were organ confined (pT1 and pT2) at the time of diagnosis. Twenty-five cases were low grade tumours (grades G1/2) and 35 were high grade (grades G3/4). At the time when the follow-up was closed (Dec 2015), 40 (66.6%) patients had died of disease. The average clinical follow up was 67.5 months (range 1–240). The elapsed time between the diagnosis of the primary tumour and the metastasis widely oscillated, from 0 to 204 months. Epithelial organs, mostly lung and pancreas, were the sites of the metastatic seed in 29 cases (48.3%), lymph nodes in 13 cases (21.6%) and soft tissues/bone in 18 cases (30%).</p> <p id="p0085"><a href="#f0010" class="usa-link">Fig. 2</a>A shows haematoxylin and eosin staining's for typical low (left hand panel) and high (right hand panel) grade ccRCC samples. ISUP grading system <a href="#bb0035" class="usa-link" aria-describedby="bb0035">[7]</a> was assigned to every sample in the TMA. Samples were grouped as low (G1/2) and high (G3/4) grades for higher consistency. <a href="#f0010" class="usa-link">Fig. 2</a>B shows fluorescent intensity maps and lifetime maps for the primary (left hand panel) and metastatic (right hand panel) tumour samples of one patient. The two-site assay was used to label pan Akt and pThr308-Akt simultaneously for each patient sample. The donor and acceptor intensity images indicate PKB/Akt and pThr308-Akt expression levels respectively. These images were equivalent to IHC images where little difference was observed between the primary and metastatic samples. Conversely, in the lifetime maps, a clear difference was observed between the samples, where lower lifetimes (see pseudo-colour scale) were indicative of higher PKB/Akt activation state. Some difference in fluorescence lifetime can be observed between the donor only samples of the primary and metastatic tumours of each patient however comparisons should be made between the donor and donor/acceptor of the same patient. <a href="#f0010" class="usa-link">Fig. 2</a>C shows the primary and metastatic PKB/Akt activation state for all patients determined by A-FRET. Some patients, such as patient 56, had a negligible PKB/Akt activation state in the primary tumour FRET Efficiency (Ef) = 0%. However, the FRET efficiency increased to 44.2% in the equivalent metastatic tumour. Thus, a low activation state of PKB/Akt did not necessarily correlate with an equivalent activation state in its corresponding metastatic evolution. <a href="#f0010" class="usa-link">Fig. 2</a>D shows the Ef of different patients plotted as Box and Whiskers distributions. The median Ef differences between primary and metastatic tumour samples were compared to noncancerous renal control tissue. The non-parametric Mann-Witney U statistical tests illustrate a significant difference between the median of the Box and Whiskers plots of primary and metastatic tumours (<em>p</em> = 3.81 × 10<sup>− 5</sup>) and between metastatic and noncancerous control tissue (<em>p</em> = 3.83 × 10<sup>− 7</sup>). The Ef parameter was utilised as a variable to assess patient prognosis. The highest 25% and lowest 75% Ef values were used to plot the Kaplan-Meier survival curves. <a href="#f0015" class="usa-link">Fig. 3</a>A shows that PKB/Akt activation state correlated with a poorer clinical outcome. The patients with the highest 25% of PKB/Akt activation were shown to have poorer prognoses when compared to the lower 75% (<em>n</em> = 16, <em>p</em> = 0.0018, HR = 0.22279 with 95% CI, 0.052–1.005). When using intensity and protein expression as a method of analysis, a significant difference was not observed between the groups (n = 16, <em>p</em> = 0.5483, HR = 1.3912 with 95% CI, 0.484–4.000). <a href="#f0015" class="usa-link">Fig. 3</a>B and C summarise Mann-Whitney <em>U</em> tests performed on the primary ccRCC tumours. These statistical analyses determined the correlations between Ef or IHC methods (pThr308-Akt-acceptor intensity) with histological grading (low (G1/2) and high (G3/4) grades) and staging (pT1/2 or pT3 in primary tumours). Neither A-FRET nor intensity determinations showed significant correlations with tumour grading or staging (confined versus not confined).</p> <figure class="fig xbox font-sm" id="f0010" title="Fig. 2"><h4 class="obj_head">Fig. 2.</h4> <p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&p=PMC3&id=5744020_gr2.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e15/5744020/04be3d97fafe/gr2.jpg" loading="lazy" height="884" width="758" alt="Fig. 2"></a></p> <div class="p text-right font-secondary"><a href="figure/f0010/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div> <figcaption><p>PKB/Akt activation is higher in metastatic ccRCC tumours in FFPE TMAs.</p> <p>A, Low-(left) and high-(right) grade ccRCCs B, the intensity images (corresponding to protein expression levels) of PKB/Akt and pAkt expression levels do not yield differences. Lifetime maps however do yield significant differences between primary and metastatic ccRCC samples. C, PKB/Akt activation state determined by A-FRET from primary to metastatic tumours for each patient. Patients 9 and 31 have higher Akt activation in their primary tumours D, the Box and Whisker plots show an increase in PKB/Akt activation from the non-tumour control tissue to the primary ccRCC cores with a significant difference of (<em>p</em> = 3.81 × 10<sup>− 5</sup>). Each point on the Box and Whisker plot indicates the activation state of the primary and metastatic tumours of each patient. A larger increase in activation is shown from primary cores to metastatic cores. <em>P</em> values are shown between significantly different groups.</p></figcaption></figure><figure class="fig xbox font-sm" id="f0015" title="Fig. 3"><h4 class="obj_head">Fig. 3.</h4> <p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&p=PMC3&id=5744020_gr3.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e15/5744020/82be1f7b6972/gr3.jpg" loading="lazy" height="829" width="711" alt="Fig. 3"></a></p> <div class="p text-right font-secondary"><a href="figure/f0015/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div> <figcaption><p>PKB/Akt activation state correlates with poor overall survival in ccRCC.</p> <p>A, shows the survival outcomes related to PKB/Akt activation as determined by A-FRET (left panel) or by conventional IHC (right panel). A highly significant difference was observed between the upper quartile of FRET Efficiency and the lower 3 quartiles FRET Efficiency. No difference was detected when survival is determined by IHC intensity of the activation state of PKB/Akt. B, Both A-FRET and IHC detections did not relate to grading (High H and Low L) <em>p</em> = 0.709 and <em>p</em> = 0.968. C, A-FRET and IHC measurements did not show significant correlations between staging (confined, c, versus non-confined, n, primary tumours) <em>p</em> = 0.774 and <em>p</em> = 0.065 respectively.</p></figcaption></figure></section></section><section id="s0060"><h2 class="pmc_sec_title">4. Discussion</h2> <p id="p0090">PKB/Akt is an oncoprotein, which is dysregulated in many human cancers <a href="#bb0025" class="usa-link" aria-describedby="bb0025">[5]</a>. Recently we have shown that its activation state is correlated to poor prognosis in breast cancer patients <a href="#bb0020" class="usa-link" aria-describedby="bb0020">[4]</a>. We also demonstrated that expression levels and activation states of oncoproteins did not necessarily correlate <a href="#bb0020" class="usa-link" aria-describedby="bb0020">[4]</a>. We therefore sought to assess whether in ccRCC patients, where the tyrosine kinase receptor pathways are dysregulated, PKB/Akt activation states would identify a worse clinical outcome. To validate this assessment, we constructed formalin-fixed paraffin embedded (FFPE) TMAs that included representative samples both of primary tumours and their metastases, either synchronic or metachronic, of 60 ccRCC patients with long-term clinical follow-up. A two-site time resolved amplified FRET method, detected by high throughput mfFLIM, was exploited to assess the functional state of PKB/Akt in these patients. Ef was utilised for determining the activation state of PKB/Akt <a href="#bb0020" class="usa-link" aria-describedby="bb0020">[4]</a>. Some differences in fluorescence lifetime occurred between donor only samples when comparing primary and metastatic samples; this is due to changes in the microenvironment between different tumours, such as pH and tissue type as metastatic tumours have the capability of creating a new tumour microenvironment in a range of tissue types. Comparisons between fluorescence lifetimes are made between donor and donor/acceptor samples of the same patient as these are tissues of the same type and from the same tumour microenvironment.</p> <p id="p0095">In summary, we have shown for the first time that the activation state of PKB/Akt in ccRCC patients, measured by A-FRET (but not by IHC intensity) was correlated with poorer overall survival. This assay is able to directly monitor the activation state of PKB/Akt in primary and metastatic ccRCC tissue, and could be used to monitor posttranslational modifications and complexes of other oncoproteins. The ability to accurately quantify the functional state of oncoproteins has important implications as a high number of ccRCCs, within their evolution, develop distant lymphatic and/or haematogenous metastases <a href="#bb0085" class="usa-link" aria-describedby="bb0085">[17]</a>, whereby the prognostic impact of classical histologic features in the primary tumour diminishes or disappears. Here prognostic models turn to the prediction of response to systemic therapy <a href="#bb0090" class="usa-link" aria-describedby="bb0090">[18]</a>. Therefore, in such a context, companion diagnostics such as A-FRET will prove valuable.</p></section><section id="s5110"><h2 class="pmc_sec_title">Transparency document</h2> <section class="sm xbox font-sm" id="ec5005"><div class="caption p"><p>Transparency document.</p></div> <div class="media p" title="Image 1"><div class="caption"> <a href="/articles/instance/5744020/bin/mmc1.pdf" data-ga-action="click_feat_suppl" class="usa-link">mmc1.pdf</a><sup> (227.5KB, pdf) </sup> </div></div></section></section><section id="ac0005" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2> <section id="s0065"><h3 class="pmc_sec_title">Acknowledgements</h3> <p id="p0100">We thank the Technical staff at the Pathology Unit at Cruces Hospital for their support and help with sample TMA preparations. <a href="#f0005" class="usa-link">Fig. 1</a> was adapted from the thesis of Madeline Parker.</p></section><section id="s0070"><h3 class="pmc_sec_title">Competing interests</h3> <p id="p0105">PL, PJP and BL are co-founders of FASTBASE Solutions, which uses A-FRET to develop insights into human disease.</p></section><section id="s0075"><h3 class="pmc_sec_title">Author contributions</h3> <p id="p0110">JM, JIL and BL. designed the experiments; JM, SW, PJP, JIL and BL. wrote the manuscript; JM, SL and CA performed the experiments; JM, CA and BL analysed the data; PL set up automated algorithm; RG, JIL made the histological evaluation and selected tumour areas for the TMAs, DJ performed the statistical analysis; all authors reviewed and approved the manuscript prior to submission.</p></section><section id="s0080"><h3 class="pmc_sec_title">Funding</h3> <p id="p0115">We also acknowledge the support of the Ikerbasque Foundation of Science; the Spanish Ministry of Economy for the grants [grant number BFU 2011-28566] to B.L.; Basque Government through the BERC 360 2014–2017; the Spanish Ministry of Economy and Competitiveness MINECO and FEDER: BCAM Severo Ochoa excellence accreditation SEV-2013-0323 to DJL.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2> <div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="s6115"><p id="p6225">The <a href="https://doi.org/10.1016/j.bbacli.2017.10.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Transparency document</a> associated with this article can be found, in online version.</p></div></div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2> <p>Jose I. López, Email: joseignacio.lopezfernandezdevillaverde@osakidetza.eus.</p> <p>Banafshé Larijani, Email: banafshe.larijani@ikerbasque.org.</p></section><section id="bi0005" class="ref-list"><h2 class="pmc_sec_title">References</h2> <section id="bi0005_sec2"><ul class="ref-list font-sm" style="list-style-type:none"> <li id="bb0005"> <span class="label">1.</span><cite>Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2016. CA Cancer J. Clin. 2016;66(1):7–30. doi: 10.3322/caac.21332.</cite> [<a href="https://doi.org/10.3322/caac.21332" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26742998/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CA%20Cancer%20J.%20Clin.&title=Cancer%20statistics,%202016&author=R.L.%20Siegel&author=K.D.%20Miller&author=A.%20Jemal&volume=66&issue=1&publication_year=2016&pages=7-30&pmid=26742998&doi=10.3322/caac.21332&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bb0010"> <span class="label">2.</span><cite>Audenet F. Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine. BJU Int. 2012;109(12):1864–1870. doi: 10.1111/j.1464-410X.2011.10661.x.</cite> [<a href="https://doi.org/10.1111/j.1464-410X.2011.10661.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22035299/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BJU%20Int.&title=Genetic%20pathways%20involved%20in%20carcinogenesis%20of%20clear%20cell%20renal%20cell%20carcinoma:%20genomics%20towards%20personalized%20medicine&author=F.%20Audenet&volume=109&issue=12&publication_year=2012&pages=1864-1870&pmid=22035299&doi=10.1111/j.1464-410X.2011.10661.x&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bb0015"> <span class="label">3.</span><cite>Hiley C. Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine. Genome Biol. 2014;15(8):453. doi: 10.1186/s13059-014-0453-8.</cite> [<a href="https://doi.org/10.1186/s13059-014-0453-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4281956/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25222836/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Biol.&title=Deciphering%20intratumor%20heterogeneity%20and%20temporal%20acquisition%20of%20driver%20events%20to%20refine%20precision%20medicine&author=C.%20Hiley&volume=15&issue=8&publication_year=2014&pages=453&pmid=25222836&doi=10.1186/s13059-014-0453-8&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bb0020"> <span class="label">4.</span><cite>Veeriah S. High-throughput time-resolved FRET reveals Akt/PKB activation as a poor prognostic marker in breast cancer. Cancer Res. 2014;74(18):4983–4995. doi: 10.1158/0008-5472.CAN-13-3382.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-13-3382" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24970478/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res.&title=High-throughput%20time-resolved%20FRET%20reveals%20Akt/PKB%20activation%20as%20a%20poor%20prognostic%20marker%20in%20breast%20cancer&author=S.%20Veeriah&volume=74&issue=18&publication_year=2014&pages=4983-4995&pmid=24970478&doi=10.1158/0008-5472.CAN-13-3382&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bb0025"> <span class="label">5.</span><cite>Bellacosa A. Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv. Cancer Res. 2005;94:29–86. doi: 10.1016/S0065-230X(05)94002-5.</cite> [<a href="https://doi.org/10.1016/S0065-230X(05)94002-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16095999/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Adv.%20Cancer%20Res.&title=Activation%20of%20AKT%20kinases%20in%20cancer:%20implications%20for%20therapeutic%20targeting&author=A.%20Bellacosa&volume=94&publication_year=2005&pages=29-86&pmid=16095999&doi=10.1016/S0065-230X(05)94002-5&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bb0030"> <span class="label">6.</span><cite>Sarbassov D.D. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 2005;307(5712):1098–1101. doi: 10.1126/science.1106148.</cite> [<a href="https://doi.org/10.1126/science.1106148" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15718470/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&title=Phosphorylation%20and%20regulation%20of%20Akt/PKB%20by%20the%20rictor-mTOR%20complex&author=D.D.%20Sarbassov&volume=307&issue=5712&publication_year=2005&pages=1098-1101&pmid=15718470&doi=10.1126/science.1106148&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bb0035"> <span class="label">7.</span><cite>Calleja V. Intramolecular and intermolecular interactions of protein kinase B define its activation in vivo. PLoS Biol. 2007;5(4):e95. doi: 10.1371/journal.pbio.0050095.</cite> [<a href="https://doi.org/10.1371/journal.pbio.0050095" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1845162/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17407381/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Biol.&title=Intramolecular%20and%20intermolecular%20interactions%20of%20protein%20kinase%20B%20define%20its%20activation%20in%20vivo&author=V.%20Calleja&volume=5&issue=4&publication_year=2007&pages=e95&pmid=17407381&doi=10.1371/journal.pbio.0050095&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bb0040"> <span class="label">8.</span><cite>Calleja V. Role of a novel PH-kinase domain interface in PKB/Akt regulation: structural mechanism for allosteric inhibition. PLoS Biol. 2009;7(1):e17. doi: 10.1371/journal.pbio.1000017.</cite> [<a href="https://doi.org/10.1371/journal.pbio.1000017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2628406/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19166270/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Biol.&title=Role%20of%20a%20novel%20PH-kinase%20domain%20interface%20in%20PKB/Akt%20regulation:%20structural%20mechanism%20for%20allosteric%20inhibition&author=V.%20Calleja&volume=7&issue=1&publication_year=2009&pages=e17&pmid=19166270&doi=10.1371/journal.pbio.1000017&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bb0045"> <span class="label">9.</span><cite>Feng J. Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. J. Biol. Chem. 2004;279(39):41189–41196. doi: 10.1074/jbc.M406731200.</cite> [<a href="https://doi.org/10.1074/jbc.M406731200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15262962/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&title=Identification%20of%20a%20PKB/Akt%20hydrophobic%20motif%20Ser-473%20kinase%20as%20DNA-dependent%20protein%20kinase&author=J.%20Feng&volume=279&issue=39&publication_year=2004&pages=41189-41196&pmid=15262962&doi=10.1074/jbc.M406731200&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bb0050"> <span class="label">10.</span><cite>Cantley L.C., Neel B.G. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. U. S. A. 1999;96(8):4240–4245. doi: 10.1073/pnas.96.8.4240.</cite> [<a href="https://doi.org/10.1073/pnas.96.8.4240" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC33561/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10200246/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20U.%20S.%20A.&title=New%20insights%20into%20tumor%20suppression:%20PTEN%20suppresses%20tumor%20formation%20by%20restraining%20the%20phosphoinositide%203-kinase/AKT%20pathway&author=L.C.%20Cantley&author=B.G.%20Neel&volume=96&issue=8&publication_year=1999&pages=4240-4245&pmid=10200246&doi=10.1073/pnas.96.8.4240&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bb0055"> <span class="label">11.</span><cite>Stemke-Hale K. An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. Cancer Res. 2008;68(15):6084–6091. doi: 10.1158/0008-5472.CAN-07-6854.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-07-6854" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2680495/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18676830/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res.&title=An%20integrative%20genomic%20and%20proteomic%20analysis%20of%20PIK3CA,%20PTEN,%20and%20AKT%20mutations%20in%20breast%20cancer&author=K.%20Stemke-Hale&volume=68&issue=15&publication_year=2008&pages=6084-6091&pmid=18676830&doi=10.1158/0008-5472.CAN-07-6854&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bb0060"> <span class="label">12.</span><cite>Carpten J.D. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature. 2007;448(7152):439–444. doi: 10.1038/nature05933.</cite> [<a href="https://doi.org/10.1038/nature05933" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17611497/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&title=A%20transforming%20mutation%20in%20the%20pleckstrin%20homology%20domain%20of%20AKT1%20in%20cancer&author=J.D.%20Carpten&volume=448&issue=7152&publication_year=2007&pages=439-444&pmid=17611497&doi=10.1038/nature05933&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bb0065"> <span class="label">13.</span><cite>Kong A. Prognostic value of an activation state marker for epidermal growth factor receptor in tissue microarrays of head and neck cancer. Cancer Res. 2006;66(5):2834–2843. doi: 10.1158/0008-5472.CAN-05-2994.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-05-2994" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16510606/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res.&title=Prognostic%20value%20of%20an%20activation%20state%20marker%20for%20epidermal%20growth%20factor%20receptor%20in%20tissue%20microarrays%20of%20head%20and%20neck%20cancer&author=A.%20Kong&volume=66&issue=5&publication_year=2006&pages=2834-2843&pmid=16510606&doi=10.1158/0008-5472.CAN-05-2994&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bb0070"> <span class="label">14.</span><cite>Valeur B. xiv. Wiley-VCH; Weinheim; Chichester: 2002. Molecular Fluorescence: Principles and Applications. (387 p.)</cite> [<a href="https://scholar.google.com/scholar_lookup?Valeur%20B.%20xiv.%20Wiley-VCH;%20Weinheim;%20Chichester:%202002.%20Molecular%20Fluorescence:%20Principles%20and%20Applications.%20(387%20p.)" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bb0075"> <span class="label">15.</span><cite>Delahunt B. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am. J. Surg. Pathol. 2013;37(10):1490–1504. doi: 10.1097/PAS.0b013e318299f0fb.</cite> [<a href="https://doi.org/10.1097/PAS.0b013e318299f0fb" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24025520/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Surg.%20Pathol.&title=The%20International%20Society%20of%20Urological%20Pathology%20(ISUP)%20grading%20system%20for%20renal%20cell%20carcinoma%20and%20other%20prognostic%20parameters&author=B.%20Delahunt&volume=37&issue=10&publication_year=2013&pages=1490-1504&pmid=24025520&doi=10.1097/PAS.0b013e318299f0fb&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bb0080"> <span class="label">16.</span><cite>Edge S.B., Compton C.C. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol. 2010;17(6):1471–1474. doi: 10.1245/s10434-010-0985-4.</cite> [<a href="https://doi.org/10.1245/s10434-010-0985-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20180029/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Surg.%20Oncol.&title=The%20American%20Joint%20Committee%20on%20Cancer:%20the%207th%20edition%20of%20the%20AJCC%20cancer%20staging%20manual%20and%20the%20future%20of%20TNM&author=S.B.%20Edge&author=C.C.%20Compton&volume=17&issue=6&publication_year=2010&pages=1471-1474&pmid=20180029&doi=10.1245/s10434-010-0985-4&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bb0085"> <span class="label">17.</span><cite>Kim H.L. Using protein expressions to predict survival in clear cell renal carcinoma. Clin. Cancer Res. 2004;10(16):5464–5471. doi: 10.1158/1078-0432.CCR-04-0488.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-04-0488" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15328185/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Cancer%20Res.&title=Using%20protein%20expressions%20to%20predict%20survival%20in%20clear%20cell%20renal%20carcinoma&author=H.L.%20Kim&volume=10&issue=16&publication_year=2004&pages=5464-5471&pmid=15328185&doi=10.1158/1078-0432.CCR-04-0488&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> <li id="bb0090"> <span class="label">18.</span><cite>Volpe A., Patard J.J. Prognostic factors in renal cell carcinoma. World J. Urol. 2010;28(3):319–327. doi: 10.1007/s00345-010-0540-8.</cite> [<a href="https://doi.org/10.1007/s00345-010-0540-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20364259/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=World%20J.%20Urol.&title=Prognostic%20factors%20in%20renal%20cell%20carcinoma&author=A.%20Volpe&author=J.J.%20Patard&volume=28&issue=3&publication_year=2010&pages=319-327&pmid=20364259&doi=10.1007/s00345-010-0540-8&" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li> </ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2> <p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p> <section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3> <section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><p>Transparency document.</p></div> <div class="media p" title="Image 1"><div class="caption"> <a href="/articles/instance/5744020/bin/mmc1.pdf" data-ga-action="click_feat_suppl" class="usa-link">mmc1.pdf</a><sup> (227.5KB, pdf) </sup> </div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless"> <p>Articles from BBA Clinical are provided here courtesy of <strong>Elsevier</strong></p></footer></section></article> </main> </div> </div> </div> <!-- Secondary navigation placeholder --> <div class="pmc-sidenav desktop:grid-col-4 display-flex"> <section class="pmc-sidenav__container" aria-label="Article resources and navigation"> <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled"> <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" /> </button> <div class="display-none desktop:display-block"> <section class="margin-top-4 desktop:margin-top-0"> <h2 class="margin-top-0">ACTIONS</h2> <ul class="usa-list usa-list--unstyled usa-list--actions"> <li> <a href="https://doi.org/10.1016/j.bbacli.2017.10.002" class="usa-button usa-button--outline width-24 font-xs usa-link--external padding-left-0 padding-right-0" target="_blank" rel="noreferrer noopener" data-ga-category="actions" data-ga-action="click" data-ga-label="publisher_link_desktop" > <span class="height-3 display-inline-flex flex-align-center">View on publisher site</span> </a> </li> <li> <a href="pdf/main.pdf" class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1" data-ga-category="actions" data-ga-action="click" data-ga-label="pdf_download_desktop" > <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden> <use xlink:href="/static/img/sprite.svg#file_download"></use> </svg> <span class="display-inline-flex flex-justify-center flex-1">PDF (777.2 KB)</span> </a> </li> <li> <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1" aria-label="Open dialog with citation text in different styles" data-ga-category="actions" data-ga-action="open" data-ga-label="cite_desktop" data-all-citations-url="/resources/citations/5744020/" data-citation-style="nlm" data-download-format-link="/resources/citations/5744020/export/" > <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden> <use xlink:href="/static/img/sprite.svg#format_quote"></use> </svg> <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span> </button> </li> <li> <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty" aria-label="Save article in MyNCBI collections." data-ga-category="actions" data-ga-action="click" data-ga-label="collections_button_desktop" data-collections-open-dialog-enabled="false" data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC5744020%2F%23open-collections-dialog" data-in-collections="false"> <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden> <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use> </svg> <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden> <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use> </svg> <span class="display-inline-flex flex-justify-center flex-1">Collections</span> </button> </li> <li class="pmc-permalink"> <button type="button" class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none" aria-label="Show article permalink" aria-expanded="false" aria-haspopup="true" data-ga-category="actions" data-ga-action="open" data-ga-label="permalink_desktop" > <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden> <use xlink:href="/static/img/sprite.svg#share"></use> </svg> <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span> </button> <div class="pmc-permalink__dropdown" hidden> <div class="pmc-permalink__dropdown__container"> <h2 class="usa-modal__heading margin-top-0 margin-bottom-2">PERMALINK</h2> <div class="pmc-permalink__dropdown__content"> <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC5744020/" aria-label="Article permalink"> <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link"> <svg class="usa-icon" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#content_copy"></use> </svg> <span class="margin-left-1">Copy</span> </button> </div> </div> </div> </li> </ul> </section> </div> <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC5744020/"> <h2 class="margin-top-0">RESOURCES</h2> <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple> <h3 class="usa-accordion__heading"> <button type="button" class="usa-accordion__button" aria-expanded="false" aria-controls="resources-similar-articles" data-ga-category="resources_accordion" data-ga-action="open_similar_articles" data-ga-label="/articles/PMC5744020/" data-action-open="open_similar_articles" data-action-close="close_similar_articles" > Similar articles </button> </h3> <div id="resources-similar-articles" class="usa-accordion__content usa-prose" data-source-url="/resources/similar-article-links/29296589/" > </div> <h3 class="usa-accordion__heading"> <button type="button" class="usa-accordion__button" aria-expanded="false" aria-controls="resources-cited-by-other-articles" data-ga-category="resources_accordion" data-ga-action="open_cited_by" data-ga-label="/articles/PMC5744020/" data-action-open="open_cited_by" data-action-close="close_cited_by" > Cited by other articles </button> </h3> <div id="resources-cited-by-other-articles" class="usa-accordion__content usa-prose" data-source-url="/resources/cited-by-links/29296589/" > </div> <h3 class="usa-accordion__heading"> <button type="button" class="usa-accordion__button" aria-expanded="false" aria-controls="resources-links-to-ncbi-databases" data-ga-category="resources_accordion" data-ga-action="open_NCBI_links" data-ga-label="/articles/PMC5744020/" data-action-open="open_NCBI_links" data-action-close="close_NCBI_link" > Links to NCBI Databases </button> </h3> <div id="resources-links-to-ncbi-databases" class="usa-accordion__content usa-prose" data-source-url="/resources/db-links/5744020/" > </div> </div> </section> <section class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4" data-title-text="On this page" data-title-heading-level="h2" data-scroll-offset="0" data-root-margin="-10% 0px -80% 0px" data-main-content-selector="main" data-threshold="1" hidden ></section> </section> </div> <div class="overlay" role="dialog" aria-label="Citation Dialog" hidden> <div class="dialog citation-dialog" aria-hidden="true"> <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2"> <h2 class="usa-modal__heading margin-0">Cite</h2> <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto" tabindex="1"> <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#close"></use> </svg> </button> </div> <div class="citation-text-block"> <div class="citation-text margin-bottom-2"></div> <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center"> <li> <button class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus" data-ga-category="save_share" data-ga-action="cite" data-ga-label="copy" tabindex="2"> <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#content_copy"></use> </svg> <span>Copy</span> </button> </li> <li> <a href="#" role="button" class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button" data-ga-category="save_share" data-ga-action="cite" data-ga-label="download" title="Download a file for external citation management software" tabindex="3"> <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#file_download"></use> </svg> <span class="display-none mobile-lg:display-inline">Download .nbib</span> <span class="display-inline mobile-lg:display-none">.nbib</span> </a> </li> <li> <div class="display-inline-flex flex-align-center"> <label class="usa-label margin-top-0">Format:</label> <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" > <option data-style-url-name="ama" value="AMA" > AMA </option> <option data-style-url-name="apa" value="APA" > APA </option> <option data-style-url-name="mla" value="MLA" > MLA </option> <option data-style-url-name="nlm" value="NLM" selected="selected"> NLM </option> </select> </div> </li> </ul> </div> </div> </div> <div class="overlay" role="dialog" hidden> <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true"> <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2"> <h2 class="usa-modal__heading margin-0">Add to Collections</h2> </div> <div class="collections-action-panel action-panel"> <form id="collections-action-dialog-form" class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors" data-existing-collections-url="/list-existing-collections/" data-add-to-existing-collection-url="/add-to-existing-collection/" data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/" data-myncbi-max-collection-name-length="100" data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/"> <input type="hidden" name="csrfmiddlewaretoken" value="yFZjJs7SnfEERH2fyDKrM44oLOjQz5huy8Gy4J7OprJvxkQWb0KCPRGQRZZhoElx"> <fieldset class="usa-fieldset margin-bottom-2"> <div class="usa-radio"> <input type="radio" id="collections-action-dialog-new" class="usa-radio__input usa-radio__input--tile collections-new margin-top-0" name="collections" value="new" data-ga-category="collections_button" data-ga-action="click" data-ga-label="collections_radio_new" /> <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label> </div> <div class="usa-radio"> <input type="radio" id="collections-action-dialog-existing" class="usa-radio__input usa-radio__input--tile collections-existing" name="collections" value="existing" checked="true" data-ga-category="collections_button" data-ga-action="click" data-ga-label="collections_radio_existing" /> <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label> </div> </fieldset> <fieldset class="usa-fieldset margin-bottom-2"> <div class="action-panel-control-wrap new-collections-controls"> <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0"> Name your collection <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr> </label> <input type="text" name="add-to-new-collection" id="collections-action-dialog-add-to-new" class="usa-input collections-action-add-to-new" pattern="[^"&=<>/]*" title="The following characters are not allowed in the Name field: "&=<>/" maxlength="" data-ga-category="collections_button" data-ga-action="create_collection" data-ga-label="non_favorties_collection" required /> </div> <div class="action-panel-control-wrap existing-collections-controls"> <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0"> Choose a collection </label> <select id="collections-action-dialog-add-to-existing" class="usa-select collections-action-add-to-existing" data-ga-category="collections_button" data-ga-action="select_collection" data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'"> </select> <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message"> Unable to load your collection due to an error<br> <a href="#">Please try again</a> </div> </div> </fieldset> <div class="display-inline-flex"> <button class="usa-button margin-top-0 action-panel-submit" type="submit" data-loading-label="Adding..." data-pinger-ignore data-ga-category="collections_button" data-ga-action="click" data-ga-label="add"> Add </button> <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel" aria-label="Close 'Add to Collections' panel" ref="linksrc=close_collections_panel" data-ga-category="collections_button" data-ga-action="click" data-ga-label="cancel"> Cancel </button> </div> </form> </div> </div> </div> </div> </div> </div> <footer class="ncbi-footer ncbi-dark-background " > <div class="ncbi-footer__icon-section"> <div class="ncbi-footer__social-header"> Follow NCBI </div> <div class="grid-container ncbi-footer__ncbi-social-icons-container"> <a href="https://twitter.com/ncbi" class="ncbi-footer__social-icon ncbi-footer__social-icon--gray" target="_blank" rel="noreferrer noopener"> <svg width="40" height="40" viewBox="0 0 40 40" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true"> <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z"> </path> </svg> <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span> </a> <a href="https://www.facebook.com/ncbi.nlm" class="ncbi-footer__social-icon ncbi-footer__social-icon--gray" target="_blank" rel="noreferrer noopener"> <svg width="16" height="29" focusable="false" aria-hidden="true" viewBox="0 0 16 29" fill="none" xmlns="http://www.w3.org/2000/svg"> <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z"> </path> </svg> <span class="usa-sr-only">NCBI on Facebook</span> </a> <a href="https://www.linkedin.com/company/ncbinlm" class="ncbi-footer__social-icon ncbi-footer__social-icon--gray" target="_blank" rel="noreferrer noopener"> <svg width="25" height="23" viewBox="0 0 26 24" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true"> <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z"> </path> <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z"> </path> <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z"> </path> </svg> <span class="usa-sr-only">NCBI on LinkedIn</span> </a> <a href="https://github.com/ncbi" class="ncbi-footer__social-icon ncbi-footer__social-icon--gray" target="_blank" rel="noreferrer noopener"> <svg width="28" height="27" viewBox="0 0 28 28" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true"> <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z"> </path> </svg> <span class="usa-sr-only">NCBI on GitHub</span> </a> <a href="https://ncbiinsights.ncbi.nlm.nih.gov/" class="ncbi-footer__social-icon ncbi-footer__social-icon--gray" target="_blank" rel="noreferrer noopener"> <svg width="26" height="26" viewBox="0 0 27 27" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true"> <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z"> </path> <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z"> </path> <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z"> </path> </svg> <span class="usa-sr-only">NCBI RSS feed</span> </a> </div> </div> <div data-testid="gridContainer" class="grid-container ncbi-footer__container"> <div class="grid-row ncbi-footer__main-content-container" data-testid="grid"> <div class="ncbi-footer__column"> <p class="ncbi-footer__circled-icons-heading"> Connect with NLM </p> <div class="ncbi-footer__circled-icons-list"> <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener"> <svg width="32" height="32" viewBox="0 0 40 40" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true"> <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z"> </path> </svg> <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span> </a> <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener"> <svg width="13" height="24" viewBox="0 0 13 24" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true"> <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z"> </path> </svg> <span class="usa-sr-only">NLM on Facebook</span> </a> <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener"> <svg width="21" height="15" viewBox="0 0 21 15" fill="none" xmlns="http://www.w3.org/2000/svg" focusable="false" aria-hidden="true"> <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z" fill="white" /> </svg> <span class="usa-sr-only">NLM on YouTube</span> </a> </div> </div> <address class="ncbi-footer__address ncbi-footer__column"> <p> <a class="usa-link usa-link--external" href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508, -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508! 4d-77.0988323" rel="noopener noreferrer" target="_blank">National Library of Medicine <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a> </p> </address> <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column"> <li class="ncbi-footer__vertical-list-item"> <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link usa-link--alt ncbi-footer__link" > Web Policies </a> </li> <li class="ncbi-footer__vertical-list-item"> <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link usa-link--alt ncbi-footer__link" > FOIA </a> </li> <li class="ncbi-footer__vertical-list-item"> <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' > HHS Vulnerability Disclosure </a> </li> </ul> <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column"> <li class="ncbi-footer__vertical-list-item"> <a href="https://support.nlm.nih.gov/" class="usa-link usa-link--alt ncbi-footer__link" > Help </a> </li> <li class="ncbi-footer__vertical-list-item"> <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link usa-link--alt ncbi-footer__link" > Accessibility </a> </li> <li class="ncbi-footer__vertical-list-item"> <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link usa-link--alt ncbi-footer__link" > Careers </a> </li> </ul> </div> <div class="grid-row grid-col-12" data-testid="grid"> <ul class="ncbi-footer__bottom-links-list"> <li class="ncbi-footer__bottom-list-item"> <a href="https://www.nlm.nih.gov/" class="usa-link usa-link--alt ncbi-footer__link" > NLM </a> </li> <li class="ncbi-footer__bottom-list-item"> <a href="https://www.nih.gov/" class="usa-link usa-link--alt ncbi-footer__link" > NIH </a> </li> <li class="ncbi-footer__bottom-list-item"> <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' > HHS </a> </li> <li class="ncbi-footer__bottom-list-item"> <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' > USA.gov </a> </li> </ul> </div> </div> </footer> <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script> <button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top"> <label>Back to Top</label> <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img"> <use xlink:href="/static/img/sprite.svg#arrow_upward"></use> </svg> </button> <script src="https://code.jquery.com/jquery-3.5.0.min.js" integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ=" crossorigin="anonymous"> </script> <script type="text/javascript">var exports = {};</script> <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script> <script type="application/javascript"> window.ncbi = window.ncbi || {}; window.ncbi.pmc = window.ncbi.pmc || {}; window.ncbi.pmc.options = { logLevel: 'INFO', staticEndpoint: '/static/', citeCookieName: 'pmc-cf', }; </script> <script type="module" crossorigin="" src="/static/assets/base-9bea7450.js"></script> <script type="module" crossorigin="" src="/static/assets/article-722d91a2.js"></script> </body> </html>